APPLICATION
ANDA200185
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-18
LATEST ACTION
2020-06-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 8MEQ · CAPSULE, EXTENDED RELEASE · ORAL
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
2020-06-10Labeling · Supplement 6 · standardAP
2015-04-14Labeling · Supplement 1AP
2011-05-18Supplement 18AP
2011-05-18UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.